Tag Archives: esrx

Drug Spending Accelerated In 2014: Express Scripts

Pharmacy benefit manager Express Scripts (ESRX) said U.S. prescription-drug spending rose more last year than it had since 2003, according to its annual review. According to the 2014 Drug Trend Report, spending on drugs among the commercially insured rose 13.1% to $980 per member last year. Medicare spending rose 13.8% to $2,987 per member, while Medicaid spending climbed 10.2% to $882. The report said that spending on hepatitis C drugs accounted

Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

Regeneron Pharmaceuticals reported solid Q4 sales, but the big cap biotech’s stock reversed lower Tuesday as its potentially huge new cholesterol fighter was in the crosshairs of a leading pharmacy benefit manager (PBM). At the JPMorgan Healthcare Conference in San Francisco, Express Scripts (ESRX) CEO George Paz chatted at a Q&A session about his company’s recent success at driving discounts to pricey new hepatitis C drugs by

CVS Covering Gilead HCV Drugs, Countering AbbVie

Monday brought a surprising turn to the twisting story of hepatitis C treatments, as pharmacy giant CVS Health said it will offer exclusive coverage for Gilead Sciences’ hep C drugs. But the key issue of price remained unanswered. The deal seemed to counterattack one cut two weeks ago between pharmacy benefit manager Express Scripts (ESRX) and AbbVie (ABBV), days after the FDA OK’d AbbVie’s four-drug Viekira Pak for genotype 1 of the